{
    "2018-11-26": [
        [
            {
                "time": "",
                "original_text": "贝达药业：实际控制人计划三月内增持不低于25万股",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "实际控制人",
                        "增持",
                        "三月内",
                        "25万股"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "早间公告：亚光科技拟回购，贝达药业实控人拟增持",
                "features": {
                    "keywords": [
                        "早间公告",
                        "亚光科技",
                        "回购",
                        "贝达药业",
                        "实控人",
                        "增持"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}